These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23147779)

  • 21. Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomas.
    Porto L; Kieslich M; Franz K; Lehrbecher T; Pilatus U; Hattingen E
    Brain Tumor Pathol; 2010 Oct; 27(2):65-70. PubMed ID: 21046307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy.
    Tzika AA; Cheng LL; Goumnerova L; Madsen JR; Zurakowski D; Astrakas LG; Zarifi MK; Scott RM; Anthony DC; Gonzalez RG; Black PM
    J Neurosurg; 2002 Jun; 96(6):1023-31. PubMed ID: 12066902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRS study of meningeal hemangiopericytoma and edema: a comparison with meningothelial meningioma.
    Righi V; Tugnoli V; Mucci A; Bacci A; Bonora S; Schenetti L
    Oncol Rep; 2012 Oct; 28(4):1461-7. PubMed ID: 22824994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors.
    Astrakas LG; Zurakowski D; Tzika AA; Zarifi MK; Anthony DC; De Girolami U; Tarbell NJ; Black PM
    Clin Cancer Res; 2004 Dec; 10(24):8220-8. PubMed ID: 15623597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
    Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo hydrogen-1 magnetic resonance spectroscopy study of human intracranial tumors.
    Luan W; Zhang J
    Chin Med J (Engl); 1998 Jan; 111(1):56-8. PubMed ID: 10322655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
    Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.
    Howe FA; Barton SJ; Cudlip SA; Stubbs M; Saunders DE; Murphy M; Wilkins P; Opstad KS; Doyle VL; McLean MA; Bell BA; Griffiths JR
    Magn Reson Med; 2003 Feb; 49(2):223-32. PubMed ID: 12541241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
    Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
    Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
    Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
    Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance.
    Thota B; Shukla SK; Srividya MR; Shwetha SD; Arivazhagan A; Thennarasu K; Chickabasaviah YT; Hegde AS; Chandramouli BA; Somasundaram K; Santosh V
    Am J Clin Pathol; 2012 Aug; 138(2):177-84. PubMed ID: 22904127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new method to classify pathologic grades of astrocytomas based on magnetic resonance imaging appearances.
    Zhao ZX; Lan K; Xiao JH; Zhang Y; Xu P; Jia L; He M
    Neurol India; 2010; 58(5):685-90. PubMed ID: 21045488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.
    Sitter B; Bathen TF; Singstad TE; Fjøsne HE; Lundgren S; Halgunset J; Gribbestad IS
    NMR Biomed; 2010 May; 23(4):424-31. PubMed ID: 20101607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N; Morales H; Modrego PJ; Pina MA
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
    Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
    Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma.
    Chan AA; Lau A; Pirzkall A; Chang SM; Verhey LJ; Larson D; McDermott MW; Dillon WP; Nelson SJ
    J Neurosurg; 2004 Sep; 101(3):467-75. PubMed ID: 15352605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations between in vivo (1)H MRS and ex vivo (1)H HRMAS metabolite measurements in adult human gliomas.
    Opstad KS; Wright AJ; Bell BA; Griffiths JR; Howe FA
    J Magn Reson Imaging; 2010 Feb; 31(2):289-97. PubMed ID: 20099340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
    Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
    NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.